You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
The Cost and Value of Anti–Epidermal Growth Factor Receptor Therapies: Let's Not Be Rash
|
---|---|
Published in |
JAMA Oncology, May 2015
|
DOI | 10.1001/jamaoncol.2015.0287 |
Pubmed ID | |
Authors |
Leonard B. Saltz |
X Demographics
The data shown below were collected from the profiles of 35 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 11 | 31% |
United Kingdom | 3 | 9% |
Saudi Arabia | 2 | 6% |
Spain | 2 | 6% |
Italy | 1 | 3% |
Netherlands | 1 | 3% |
Paraguay | 1 | 3% |
Australia | 1 | 3% |
Germany | 1 | 3% |
Other | 0 | 0% |
Unknown | 12 | 34% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 19 | 54% |
Scientists | 8 | 23% |
Practitioners (doctors, other healthcare professionals) | 7 | 20% |
Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Ecuador | 1 | 13% |
Unknown | 7 | 88% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 2 | 25% |
Lecturer > Senior Lecturer | 1 | 13% |
Lecturer | 1 | 13% |
Other | 1 | 13% |
Student > Master | 1 | 13% |
Other | 1 | 13% |
Unknown | 1 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 75% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 13% |
Unknown | 1 | 13% |
Attention Score in Context
This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 June 2016.
All research outputs
#1,302,590
of 25,373,627 outputs
Outputs from JAMA Oncology
#1,743
of 3,308 outputs
Outputs of similar age
#16,013
of 278,920 outputs
Outputs of similar age from JAMA Oncology
#50
of 78 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,308 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 84.4. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,920 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 78 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.